3-[211At]astato-4-fluorobenzylguanidine: A potential therapeutic agent with prolonged retention by neuroblastoma cells
Publication
, Journal Article
Vaidyanathan, G; Zhao, XG; Larsen, RH; Zalutsky, MR
Published in: British Journal of Cancer
1997
Duke Scholars
Published In
British Journal of Cancer
Publication Date
1997
Volume
76
Issue
2
Start / End Page
226 / 233
Related Subject Headings
- Oncology & Carcinogenesis
- 1117 Public Health and Health Services
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Vaidyanathan, G., Zhao, X. G., Larsen, R. H., & Zalutsky, M. R. (1997). 3-[211At]astato-4-fluorobenzylguanidine: A potential therapeutic agent with prolonged retention by neuroblastoma cells. British Journal of Cancer, 76(2), 226–233.
Vaidyanathan, G., X. G. Zhao, R. H. Larsen, and M. R. Zalutsky. “3-[211At]astato-4-fluorobenzylguanidine: A potential therapeutic agent with prolonged retention by neuroblastoma cells.” British Journal of Cancer 76, no. 2 (1997): 226–33.
Vaidyanathan G, Zhao XG, Larsen RH, Zalutsky MR. 3-[211At]astato-4-fluorobenzylguanidine: A potential therapeutic agent with prolonged retention by neuroblastoma cells. British Journal of Cancer. 1997;76(2):226–33.
Vaidyanathan, G., et al. “3-[211At]astato-4-fluorobenzylguanidine: A potential therapeutic agent with prolonged retention by neuroblastoma cells.” British Journal of Cancer, vol. 76, no. 2, 1997, pp. 226–33.
Vaidyanathan G, Zhao XG, Larsen RH, Zalutsky MR. 3-[211At]astato-4-fluorobenzylguanidine: A potential therapeutic agent with prolonged retention by neuroblastoma cells. British Journal of Cancer. 1997;76(2):226–233.
Published In
British Journal of Cancer
Publication Date
1997
Volume
76
Issue
2
Start / End Page
226 / 233
Related Subject Headings
- Oncology & Carcinogenesis
- 1117 Public Health and Health Services
- 1112 Oncology and Carcinogenesis